On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios
暂无分享,去创建一个
Peter G. M. van der Heijden | Stef van Buuren | S. Buuren | Eugène van Puijenbroek | Jacques W van der Hofstede | E. Puijenbroek | P. Heijden
[1] D. J. Finney,et al. stematic Signalling of Adverse Reactions to Drugs , 1974, Methods of Information in Medicine.
[2] B. Bégaud,et al. Is reporting rate a good predictor of risks associated with drugs? , 1999, British journal of clinical pharmacology.
[3] R. Meyboom,et al. Non-puerperal lactation associated with antidepressant drug use. , 2003, British journal of clinical pharmacology.
[4] F. Baudraz-Rosselet,et al. Treatment of onychomycosis with terbinafine , 1992, The British journal of dermatology.
[5] A. Egberts,et al. Detecting drug–drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs , 2000, European Journal of Clinical Pharmacology.
[6] A. Agresti,et al. Categorical Data Analysis , 1991, International Encyclopedia of Statistical Science.
[7] M. D. B. Stephens,et al. The detection of new adverse drug reactions , 1985 .
[8] M. Praus,et al. Alert systems for post-marketing surveillance of adverse drug reactions. , 1993, Statistics in medicine.
[9] Rawlins,et al. Attitudinal survey of voluntary reporting of adverse drug reactions. , 1999, British journal of clinical pharmacology.
[10] W. O'Brien,et al. Adverse reactions to nonsteroidal anti-inflammatory drugs. Diclofenac compared with other nonsteroidal anti-inflammatory drugs. , 1986, The American journal of medicine.
[11] D. Grobbee,et al. Adverse Cardiovascular Effects of NSAIDs in Patients with Congestive Heart Failure , 1997, Drug safety.
[12] D. J. Finney,et al. Statistical Logic in the Monitoring of Reactions to Therapeutic Drugs , 1971, Methods of Information in Medicine.
[13] S J Evans,et al. Pharmacovigilance: a science or fielding emergencies? , 2000, Statistics in medicine.
[14] L. Wilton,et al. Underreporting of suspected adverse drug reactions to newly marketed (“black triangle”) drugs in general practice: observational study , 1998, BMJ.
[15] D. J. Finney,et al. The detection of adverse reactions to therapeutic drugs. , 1982, Statistics in medicine.
[16] B. Stricker,et al. Serum sickness-like reactions to cefaclor. , 1992, Journal of clinical epidemiology.
[17] J. Ottervanger,et al. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. , 1998, Archives of internal medicine.
[18] R. Meyboom,et al. Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. , 1999, British journal of clinical pharmacology.
[19] William DuMouchel,et al. Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System , 1999 .
[20] Patrick C. Waller,et al. Responding to drug safety issues , 1999, Pharmacoepidemiology and drug safety.
[21] Y. Tsong,et al. Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trends in total reporting. , 1995, Journal of biopharmaceutical statistics.